Anders Dyhr Toft waves goodbye to Novo Nordisk after 18 years to become the CMO of Synact: "It's going to be more DIY-based"
After almost two decades working for Novo Nordisk, Anders Dyhr Toft changes the scenery of his professional life to biotech company Synact Pharma to be the new CMO. According to the person in question, he felt the need to try out a different culture and pacing, as well as a new level of risk-taking.
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN
A freer bird now, but with smaller wings.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
EMA currently sees no need for Covid booster jab
For subscribers
.jpg&w=384&q=75)
